[Adrenoleukodystrophy: the significance of peroxisomal disease in adult neurology].
Gold
R
R
Max-Planck-Gesellschaft, Klinische Forschungsgruppe für Multiple Sklerose.
Hunneman
D H
DH
Kappos
L
L
Hanefeld
F
F
D000326:Adrenoleukodystrophy / Q000175:diagnosis* / Q000235:genetics; D000328:Adult; D001921:Brain / Q000473:pathology; D003937:Diagnosis, Differential; D002549:Diffuse Cerebral Sclerosis of Schilder / Q000175:diagnosis*; D005227:Fatty Acids / Q000378:metabolism; D006580:Genetic Carrier Screening; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008830:Microbodies / Q000201:enzymology; D010088:Oxidoreductases / Q000378:metabolism
D005227:Fatty Acids; D010088:Oxidoreductases
Adrenoleukodystrophie: die Bedeutung einer peroxisomalen Erkrankung in der Erwachsenenneurologie.